The World Health Organization (WHO) has reported that drug resistance to HIV is on the rise. The number of persons infected with the HIV who are receiving antiretroviral therapy has risen to 27.5 million. It has grown by two million people every year.
According to WHO’s HIV drug-resistance study, four out of five countries with high incidence have experienced progress in suppressing the virus with antiretroviral therapies.
The study also discovered an increase in nations achieving a 10% threshold of resistance to a class of medications. The necessity for a shift to an alternate therapy, which has been suggested since 2019, has been emphasized.
Resistance surpassing the 10% criterion was recorded in 21 of the 30 nations assessed in the study.
According to studies conducted in ten Sub-Saharan African countries, switching from non-nucleoside reverse transcriptase inhibitors was crucial for children. Almost half of all newborns were found to be infected with drug-resistant HIV.
The study, according to Meg Doherty, director of WHO’s global HIV, hepatitis, and STI programs, holds states accountable for monitoring medication resistance and ensuring effective treatment for patients.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.